AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2007

Dec 18, 2007

34117_dirs_2007-12-18_25bb440a-6eca-4827-96f1-3ed8faea380e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2007-10-31

Reporting Person: KRUSOS DENIS A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-06-05	Common Stock	G	100000	—	Disposed	2421130	Direct
2007-06-14	Common Stock	G	100000	—	Disposed	2421130	Direct
2007-09-26	Common Stock	G	100000	—	Disposed	2421130	Direct

Footnotes

F1: Amount of securities beneficially owned represents shares held by Denis A. Krusos as of October 31, 2007 and excludes shares
Mr. Krusos has the right to acquire upon exercise of stock options pursuant to CopyTele, Inc. stock incentive plans

F2: Gift.